APIS India Limited has formally disclosed to BSE Limited that it does not qualify as a Large Corporate as on March 31, 2026. The disclosure was made through an official communication dated April 16, 2026, in compliance with specific SEBI regulations governing debt securities issuance by large entities.

Regulatory Compliance Details

The disclosure was made pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, read with SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023. These circulars specifically address fund raising by issuance of debt securities by large entities. The company also referenced BSE Circular No. LIST/COMP/05/2019-20 dated April 11, 2019 in its communication.

Corporate Information

The disclosure was signed by Amit Anand, Managing Director of APIS India Limited, with DIN 00951321. The communication was digitally signed on April 16, 2026, at 12:46:45 +05'30'. The company maintains its registered office at 18/32, East Patel Nagar, New Delhi-110008, with manufacturing works located at Khasra No. 66-72, Makhiali Dundli, Peerpura Road, Roorkee-247667, Uttarakhand.

Significance of Large Corporate Classification

The Large Corporate classification under SEBI regulations determines specific compliance requirements for companies, particularly regarding debt securities issuance. By confirming its non-Large Corporate status as on March 31, 2026, APIS India Limited has clarified its regulatory standing for stakeholders and market participants. This disclosure ensures transparency and compliance with current regulatory frameworks governing corporate debt market participation.

Apis India Limited has announced the resignation of its National Sales Head, Mr. Sharad Vatss, through a regulatory filing with the BSE on April 16, 2026. The resignation became effective from the closure of business hours on April 15, 2026.

Regulatory Compliance and Filing Details

The company submitted the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with Schedule III provisions. The filing was signed by Managing Director Amit Anand and includes reference number AIL/CS/2026-27/466.

Resignation Details

According to the mandatory disclosure requirements, the company provided comprehensive information about the leadership change:

Compliance Framework

The disclosure follows SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, ensuring full regulatory compliance. The company has also uploaded the intimation on its official website at www.apisindia.com for public access.

Company Information

Apis India Limited operates from its registered office at East Patel Nagar, New Delhi, with manufacturing works located in Roorkee, Uttarakhand. The pharmaceutical company maintains transparency in corporate governance through timely regulatory filings and stakeholder communications.